The Japanese government has stated in a recent annual policy guideline on general economic policies that it will conduct a review of the entire generic drug industry, while also discussing how to improve stability in the supply chain to address ongoing domestic shortages of certain products.
Japan Mulls Pricing Changes, Generic Sector Review Amid Ongoing Shortages
Set Of New Govt Proposals
To stabilize now years-old pharmaceutical supply shortages, especially from generic firms, Japan will review several regulations related to the sector and aspects of its reimbursement pricing scheme. Recently announced economic policies and an official report also refer to potential measures to encourage businesses through financial support and revised pricing premiums.
